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OPEN
LETTER TO THE EDITOR
Neonatal pigs are susceptible to experimental Zika virus
infection
Joseph Darbellay1,2, Kenneth Lai1, Shawn Babiuk3, Yohannes Berhane3, Aruna Ambagala3, Colette Wheler1,
Donald Wilson1, Stewart Walker1, Andrew Potter1, Matthew Gilmour4, David Safronetz4, Volker Gerdts1,2
and Uladzimir Karniychuk1,2
Emerging Microbes & Infections (2017) 6, e6; doi:10.1038/emi.2016.133; published online 15 February 2017
Dear Editor,
The current Zika virus (ZIKV; genus Flavivirus) epidemic in the
Western Hemisphere has been declared a public health emergency.
The virus can cause transplacental infections in pregnant women,
resulting in microcephaly of the fetus, intrauterine growth restriction
and abortions.1 In addition, regions with the heaviest ZIKV burden are
endemic for dengue virus (DENV). It is possible that ZIKV infection
or vaccination may enhance DENV infections, and render mild
dengue fever into a life-threatening disease.2 Animal models to study
ZIKV infection and ZIKV co-infections with other flaviviruses are
crucial for further fundamental studies and development of effective
interventions. To date, significant efforts have been made to develop
only mouse and non-human primate models3 for ZIKV infection. The
identification of another mammalian species able to at least partially
model ZIKV infections in humans has significant value. It has been
previously reported that flaviviruses, including DENV,4 West Nile
virus5 and Japanese encephalitis virus,6 can infect domestic pigs.
Therefore, we designed this preliminary study to determine whether
neonatal pigs are susceptible to ZIKV infection.
First, we determined the susceptibility of one-day-old piglets to
ZIKV infection. Two pregnant Landrace-cross sows were housed at
the VIDO-InterVac. After farrowing, newborn piglets were challenged
with 1 mL of inoculum containing 5.8 log10 50% tissue culture
infectious dose (TCID50)/mL of ZIKV strain PRVABC59 (GenBank:
KU501215), which was isolated from human serum collected in
Puerto Rico in December 2015 and was provided by the Centers for
Disease Control and Prevention, Division of Vector-Borne Diseases,
Fort Collins, Colorado, USA. Virus stocks were prepared by inoculat-
ing a confluent monolayer of Vero E6 cells. We selected a viral
challenge dose within the previously reported range for West Nile
virus: 102–107 infectious viral particles during a mosquito bite.7
A prior study also indicated a ZIKV load of up to 108 TCID50 in
the salivary gland of the Aedes aegypti mosquito.8 Eleven piglets
were inoculated intracerebrally (IC), six piglets were inoculated
intradermally (ID) in four sites on the neck skin and six piglets were
inoculated intraperitoneally (IP). Three control mock-inoculated
(IC-inoculated) and non-manipulated piglets were also included in
the study. Animals were monitored daily for clinical signs. Blood was
collected at three, five and seven days post virus inoculation (dpi). At
each sampling time point, two piglets in the ID and IP groups and
three to four piglets in the IC group were euthanized to collect urine
(aspirated from the bladder), brain and spleen. Tissues were snap-
frozen for virological analyses. A previously published ZIKV-specific
real-time reverse transcription polymerase chain reaction (RT-PCR)
SYBR Green assay was used to identify and quantify ZIKV RNA. Zika
virus titers were identified by inoculation on Vero E6 cells and
subsequent staining with ZIKV-specific antibodies (Ab; anti-ZIKV
rabbit polyclonal Ab; IBT BIOSERVICES, MD, USA). The infectious
virus in brain tissues was also isolated on mosquito C6/36 cells. For
quantification of ZIKV-specific IgM, IgG Ab and neutralizing Ab
(NAb), modified immunoperoxidase monolayer assay and neutralizing
assay were used, respectively. A detailed description of experimental
methods is provided in Supplementary Methods.
Mock-inoculated and non-manipulated animals did not exhibit any
clinical signs, ZIKV RNA, live virus titers or virus-specific Ab. At 5
dpi, two ZIKV IC-inoculated piglets of eleven exhibited leg weakness,
ataxia and tremor (Supplementary Videos 1 and 2). Similar clinical
signs have been reported in ZIKV-infected neonatal mice9 and a
human adult who died because of encephalitis associated with ZIKV
infection.10 In the IC-inoculated piglets, ZIKV RNA in sera was
detected at 3, 5 and 7 dpi, whereas ID- and IP-inoculated piglets were
positive at 3 and 5 dpi (Figure 1A). In the IC-inoculated piglets, the live
virus was detected in sera at 3 and 5 dpi (Figure 1B). Intradermally and
IP-inoculated piglets had live ZIKV at 3 dpi, except one ID-inoculated
piglet that was positive at 5 dpi. Analysis of variance on ranks
exhibited significant differences between IC and IP groups at 5 dpi
(P= 0.02). ZIKV RNA and live virus were also identified in urine
(IC and ID groups), brain (only IC group) and spleen (IC, ID and IP
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groups; Supplementary Table S1). Brain samples were negative for
infectious ZIKV on Vero E6 cells. From personal communications
with other researchers and publications on the conventional mouse11
and non-human primate models,12 we know that Vero E6 cells may be
not sensitive enough for ZIKV isolation from tissues. Alternatively, a
load of infectious virus in brain tissues from conventional animals may
be too small to be isolated on Vero E6 cells. However, inoculation of
more sensitive C6/36 cells with brain suspensions (Supplementary
Materials) resulted in the isolation of infectious ZIKV (Supplementary
Table S1). Serum samples from all groups were positive for ZIKV IgM
Abs (IC group - 2–4 log2; ID and IP groups - 3 log2) at 7 dpi. In
addition, weak NAb activity was observed in sera (IC group – 2–2.6
log2; ID – 1.6-3.6 log2; and IP – 1.6–2 log2) at 7 dpi.
Second, to further confirm the infectivity of ZIKV in tissue and
serum samples from challenged animals and the susceptibility of pigs
to the lower infectious doses, we performed a serial passage experi-
ment. In addition, we verified the feasibility of experimental ZIKV
passage on pigs given that human viruses adapted to animals via serial
passage might be a useful tool to study disease pathogenesis, virus
interactions with a new host and viral evolution. In the serial passage
experiment, two newborn piglets (Figure 1C – Passage 1) were
inoculated IC with 1 mL of serum or 1 mL of brain suspension in
PBS (1:1 volumes) obtained from a piglet inoculated IC with 1 mL of
inoculum containing 5.8 log10 TCID50 of ZIKV (Figure 1C – Initial
challenge). Both newborn piglets inoculated IC with either the pig
serum or brain suspension containing low ZIKV doses (serum= 1.8
log10 TCID50/mL; brain suspensiono1.2 log10 TCID50/g) had viremia
at 4–6 dpi (Figure 1C – Passage 1). We used sera collected at 6 dpi
from the piglet inoculated with brain suspension to perform the
second IC passage in two older, six-day-old piglets. These animals
developed viremia at 4–6 dpi (Figure 1C – Passage 2) and high titers of
ZIKV IgM and IgG Abs at 9–14 and 10–14 dpi, respectively
(Figure 1D). IgM and IgG Abs were primarily detected two days later
than in the first challenge experiment, and this effect was likely
attributable to the much lower ZIKV inoculation dose. Piglets also
developed moderate NAb responses at 9–14 dpi (Figure 1D). Kinetics
of ZIKV Ab responses in pigs were similar to those in humans.13
Neutralizing Ab titers in pigs were also similar to NAb responses in
experimentally inoculated rhesus macaques.3
In this preliminary study, we found that ZIKV infects conventional
neonatal pigs, causing viremia, viruria and virus replication in internal
organs. We also demonstrated that one-day-old and six-day-old piglets
are susceptible to a low infectious dose of ZIKV and that experimental
serial passage is feasible. The serial passage of ZIKV on pigs may be a
useful approach to generate ZIKV strains for pathogeneses and
evolutionary studies.
Most importantly, pigs inoculated with ZIKV via different routes
developed IgM, IgG, and neutralizing Abs, which may provide
opportunities to study the antibody-dependent enhancement (ADE)
of other flavivirus infections. For example, the major risk factor for
developing severe dengue fever is ADE of infection caused by the
presence of DENV-reactive Ab from a previous infection with a
different DENV serotype. Antibodies induced by previous infections
with other related flaviviruses may cause the same detrimental
effects. In support, polyclonal mouse Ab against ZIKV enhanced
DENV infection in vitro.2 Transfer of ZIKV monoclonal Ab to
immunocompromised mice also enhanced subsequent DENV
infections.14 Thus, ZIKV vaccination or infection may enhance DENV
infections and render mild dengue fever into a life-threatening disease.
To the authors’ knowledge, ZIKV co-infections with DENV or other
flaviviruses have not been tested in vivo. Previously published mouse
models of ADE during DENV infection utilize immunocompromised
mice and passive Ab transfer. The work on non-human primate is not
feasible to most research groups and is constrained by economic
boundaries. As an alternative, conventional pigs are susceptible to
DENV4 and to other human flaviviruses, including West Nile virus5
and Japanese encephalitis virus.6 Furthermore, human infants have the
major risk of developing severe dengue fever as a result of ADE of
infection due to DENV-reactive Ab acquired from an immune
mother.15 Thus, neonatal pigs might be used to model ZIKV and
DENV (or another flavivirus) co-infections and ADE of infection
in infants.
Beyond modeling ZIKV infection, our data may have epidemiological
applications. Given that ZIKV is an emerging pathogen in the Americas,
it is difficult to predict potential reservoirs of the virus as it spreads in
the new environment. Japanese encephalitis virus, another member of
the family Flaviviridae, uses pigs as amplifying hosts with subsequent
mosquito-mediated transmission to humans. Therefore, additional
studies are necessary to clarify if ZIKV has the potential to establish
endemic infections in swine herds and a sylvatic cycle involving pigs.
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